Methylenetetrahydrofolate reductase gene and risk of Alzheimer's disease in Koreans

International Journal of Geriatric Psychiatry

Volumn 23, Issue 5, 2008, Pages 454-459

  Kim, Jae Min ^a   Stewart, Robert ^b   Kim, Sung Wan ^a   Yang, Su Jin ^a   Shin, Il Seon ^a   Shin, Hee Young ^c   Yoon, Jin Sang ^a,c  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Alzheimer's disease; Dementia; Genetics; Methylenetetrahydrofolate reductase (MTHFR); One carbon metabolism

Indexed keywords

APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; TRANSFERASE;

AGE; AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; ASSAY; CARBON METABOLISM; CONTROLLED STUDY; DEMENTIA; EDUCATIONAL STATUS; FEMALE; FOLIC ACID BLOOD LEVEL; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; KOREA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RISK FACTORS; VITAMIN B 12;

EID: 44249095104     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1903     Document Type: Article

References (36)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorder, 4th edn. American Psychiatric Press: Washington, DC.
2. Anello G, Gueant-Rodriquez RM, Bosco P, et al. 2004. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 15: 859-861.
3. Bosco P, Guéant-Rodríguez R-M, Anello G, et al. 2004. Association of IL-1 RN*2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 75: 1036-1038.
4. Bottiglieri T, Parnetti L, Arning E, et al. 2001. Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia. Mech Ageing Dev 122: 2013-2023.
5. Brunelli T, Bagnoli S, Giusti B, et al. 2001. The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease. Neurosci Lett 316: 103-107.
6. Chapman J, Wang N, Treves TA, et al. 1998. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 29: 1401-1404.
7. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-14455.
8. Frosst P, Blom HJ, Milos R, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
9. Ho PI, Collins SC, Dhitavat S, et al. 2001. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem 78: 249-253.
10. Hughes CP, Berg L, Danziger WL, et al. 1982. A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572.
11. Keikhaee MR, Hashemi SB, Najmabadi H, Noroozian M. 2006. C677T methylentetrahydrofulate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population. Neurochem Res 31: 1079-1083.
12. Kim JM, Stewart R, Shin IS, et al. 2004. Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population. Neurobiol Aging 25: 295-301.
13. Kim JM, Stewart R, Shin IS, Yoon JS. 2003. Limb length and dementia in an older Korean population. J Neurol Neurosurg Psychiatry 74: 427-432.
14. Lawton MP, Brody EM. 1969. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: 179-186.
15. Lindenbaum J, Healton EB, Savage DG, et al. 1988. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Eng J Med 318: 1720-1728.
16. Linnebank M, Linnebank A, Jeub M, et al. 2004. Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am J Med Genet A 131: 101-102.
17. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939-944.
18. Nishiyama M, Kato Y, Hashimoto M, et al. 2000. Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia - an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol 10: 163-172.
19. Park J, Ko HJ, Park YN, Jung CH. 1994. Dementia among the elderly in a rural Korean community. Br J Psychiatry 164: 796-801.
20. Park JH, Kwon YC. 1990. Modification of the mini-mental state examination for use in the elderly in a non-western society: part I. development of Korean version of Mini-Mental State Examination. Int J Geriatr Psychiatry 5: 381-387.
21. Pollak RD, Pollak A, Idelson M, et al. 2000. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc 48: 664-668.
22. Postiglione A, Milan G, Ruocco A, et al. 2001. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology 47: 324-329.
23. Prince M, Acosta D, Chiu H, et al. and the 10/66 Dementia Research Group. 2003. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361: 909-917.
24. Quadri P, Fragiacomo C, Pezzati R, et al. 2004. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80: 114-122.
25. Ravaglia G, Forti P, Maioli F, et al. 2004. Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern Italian subjects. Arch Gerontol Geriatr Suppl 9: S339-S348.
26. Religa D, Styczynska M, Peplonska B, et al. 2003. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16: 64-70.
27. Roman GC, Tatemichi TK, Erkinjuntti T, et al. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINCDS-AIREN International Work Group. Neurology 43: 250-260.
28. Seripa D, Forno GD, Matera MG, et al. 2003. Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurubiol Aging 24: 933-939.
29. Suh GH, Shah A. 2001. A review of the epidemiological transition in dementia-cross-national comparisons of the indices related to Alzheimer's disease and vascular dementia. Acta Psychiatr Scand 104: 4-11.
30. Tysoe C, Galinsky D, Robinson D, et al. 1997. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet 74: 207-212.
31. Ueland PM, Hustad S, Schneede J, et al. 2001. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22: 195-201.
32. Wakutani Y, Kowa H, Kusumi M, et al. 2002. Genetic analysis of vascular factors in Alzheimer's disease. Ann NY Acad Sci 977: 232-238.
33. Wang B, Jin F, Kan R, et al. 2005. Association of MTHFR gene polymorphism C677T with susceptibility ot late-onset Alzheimer's disease. J Mol Neurosci 27: 23-27.
34. Yoo JH, Choi GD, Kang SS. 2000. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 20: 1921-1925.
35. Zivelin A, Rosenberg N, Peretz H, et al. 1997. Improved method for genotyping apolipoprotein E polymorphins by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 43: 1657-1659.
36. Zuliani G, Ble' A, Zanca R, et al. 2001. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand 103: 304-308.